swtx: the income statement

MyFinsight

SpringWorks Therapeutics, Inc. (SWTX)

For the year ending 2024-12-31, SWTX made $191,589K in revenue. -$258,131K in net income. Net profit margin of -134.73%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2024-12-31
Total revenue	191,589
Selling, general and administrative	256,652
Research and development	200,518
Cost of product revenue	12,550
Total operating expenses	469,720
Loss from operations	-278,131
Interest and other income, net	26,000
Total interest and other income	26,000
Equity method investment loss	-6,000
Net loss	-258,131

Basic eps	-3.48
Diluted eps	-3.48
Basic average shares	74,132,811
Diluted average shares	74,132,811

Unit: Thousand (K) dollars (except for numbers of shares and EPS)